Skip to main content
Journal cover image

Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.

Publication ,  Journal Article
Calkins, MJ; Jakel, RJ; Johnson, DA; Chan, K; Kan, YW; Johnson, JA
Published in: Proc Natl Acad Sci U S A
January 4, 2005

Complex II inhibitors 3-nitropropionic acid (3NP) and malonate cause striatal damage reminiscent of Huntington's disease and have been shown to involve oxidative stress in their pathogenesis. Because nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent transcriptional activation by means of the antioxidant response element is known to coordinate the up-regulation of cytoprotective genes involved in combating oxidative stress, we investigated the significance of Nrf2 in complex II-induced toxicity. We found that Nrf2-deficient cells and Nrf2 knockout mice are significantly more vulnerable to malonate and 3NP and demonstrate increased antioxidant response element (ARE)-regulated transcription mediated by astrocytes. Furthermore, ARE preactivation by means of intrastriatal transplantation of Nrf2-overexpressing astrocytes before lesioning conferred dramatic protection against complex II inhibition. These observations implicate Nrf2 as an essential inducible factor in the protection against complex II inhibitor-mediated neurotoxicity. These data also introduce Nrf2-mediated ARE transcription as a potential target of preventative therapy in neurodegenerative disorders such as Huntington's disease.

Duke Scholars

Published In

Proc Natl Acad Sci U S A

DOI

ISSN

0027-8424

Publication Date

January 4, 2005

Volume

102

Issue

1

Start / End Page

244 / 249

Location

United States

Related Subject Headings

  • Transcription, Genetic
  • Trans-Activators
  • Succinate Dehydrogenase
  • Propionates
  • Nitro Compounds
  • NF-E2-Related Factor 2
  • Mice
  • Malonates
  • Humans
  • Genes, Reporter
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A. (2005). Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci U S A, 102(1), 244–249. https://doi.org/10.1073/pnas.0408487101
Calkins, Marcus J., Rebekah J. Jakel, Delinda A. Johnson, Kaimin Chan, Yuet Wai Kan, and Jeffrey A. Johnson. “Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.Proc Natl Acad Sci U S A 102, no. 1 (January 4, 2005): 244–49. https://doi.org/10.1073/pnas.0408487101.
Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):244–9.
Calkins, Marcus J., et al. “Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.Proc Natl Acad Sci U S A, vol. 102, no. 1, Jan. 2005, pp. 244–49. Pubmed, doi:10.1073/pnas.0408487101.
Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):244–249.
Journal cover image

Published In

Proc Natl Acad Sci U S A

DOI

ISSN

0027-8424

Publication Date

January 4, 2005

Volume

102

Issue

1

Start / End Page

244 / 249

Location

United States

Related Subject Headings

  • Transcription, Genetic
  • Trans-Activators
  • Succinate Dehydrogenase
  • Propionates
  • Nitro Compounds
  • NF-E2-Related Factor 2
  • Mice
  • Malonates
  • Humans
  • Genes, Reporter